Cyanotech Stock Price, News & Analysis
Company Description
Cyanotech Corporation (OTCQB: CYAN) is a manufacturing company in the medicinal and botanical space that focuses on microalgae-based, high-value nutrition and health dietary supplement products. According to the company’s disclosures, Cyanotech describes itself as a world leader in microalgae technology for more than 30 years, and in some releases notes a history of more than 40 years. The company’s operations center on producing natural dietary ingredients and supplements that promote health and well-being.
Core products and brands
Cyanotech produces two flagship microalgae-derived product lines: BioAstin® Hawaiian Astaxanthin® and Hawaiian Spirulina Pacifica®. These are described as all‑natural dietary ingredients and supplements. The company states that BioAstin Hawaiian Astaxanthin offers superior antioxidant activity that supports skin, eye and joint health, as well as recovery from exercise, while its Spirulina products provide nutrition that supports cardiovascular health and immunity. The company notes that related product benefit statements have not been evaluated by the U.S. Food and Drug Administration and that the products are not intended to diagnose, treat, cure, or prevent any disease.
Through its wholly owned subsidiary Nutrex-Hawaii, Inc., Cyanotech also markets consumer dietary supplements based on these same microalgae ingredients. Nutrex-Hawaii identifies itself as a global leader in natural, premium microalgae dietary supplements for health and wellness, built around the BioAstin Hawaiian Astaxanthin and Hawaiian Spirulina Pacifica brands.
Microalgae production and technology
Cyanotech emphasizes that all of its products are produced from microalgae grown at a 96‑acre facility in Kona, Hawaii. The company states that this facility is purpose-built for microalgae cultivation and uses patented and proprietary technology. Cyanotech highlights that its microalgae are naturally and sustainably produced, grown outdoors under natural sun in Hawaii, and that this approach supports origin traceability and sustainability. The company notes that its microalgae-derived ingredients are Generally Recognized as Safe (GRAS) for use in food products.
In its communications, Cyanotech links its mission to “fulfill the promise of whole health through Hawaiian microalgae.” The company positions its naturally farmed microalgae from Hawaii’s “pristine waters” and natural sourcing practices as aligned with consumer interest in responsible, sustainable and U.S.-grown products.
Business model and distribution
Cyanotech operates in the manufacturing sector, with a focus on medicinal and botanical manufacturing of microalgae-based ingredients and finished supplements. The company reports that it sells products direct to consumers at retail locations in the United States and through online channels under the Nutrex-Hawaii brand. It also states that it distributes ingredients and products to dietary supplement, nutraceutical and cosmeceutical manufacturers and marketers, reflecting both business-to-consumer and business-to-business channels.
Nutrex-Hawaii notes that its products are distributed through premium retail locations in the United States and online platforms, and that they are trusted by consumers worldwide. Cyanotech’s financial news releases frequently distinguish between packaged sales (consumer-facing products) and bulk sales (ingredient sales), as well as revenue from contract extraction, indicating multiple revenue streams within its microalgae business.
Regulatory environment
Cyanotech reports that it is regulated by the U.S. Food and Drug Administration (FDA) in connection with its dietary supplement and food ingredient activities. The company repeatedly includes standard dietary supplement disclaimers that product benefit statements have not been evaluated by the FDA and that the products are not intended to diagnose, treat, cure or prevent any disease. The company also files periodic reports such as Forms 10‑K and 10‑Q with the U.S. Securities and Exchange Commission, as referenced in its earnings announcements.
Financial reporting and trading venue
Cyanotech provides regular financial updates, including quarterly and annual results, and refers investors to its Form 10‑K and Form 10‑Q filings for more detailed information. Recent press releases describe trends in net sales, gross profit, operating income or loss, and net income or loss over various periods. The company’s shares trade on the OTCQB market under the symbol CYAN, and prior releases reference trading on the Nasdaq Capital Market under the same ticker before the move to OTCQB noted in later news.
Strategic focus and operations
In its public statements, Cyanotech highlights several ongoing areas of focus:
- Operational efficiency and cost discipline, including efforts to improve gross margin through higher production volumes and lower per‑unit costs.
- Inventory management, such as adjusting inventory levels, restocking bulk and packaged goods, and managing production to balance cash flow with demand.
- Brand-building and marketing, including differentiated storytelling for its brands, restructuring of sales teams, and aligning marketing materials with themes of transparency, sustainability and farm-direct quality.
- Channel development in key e‑commerce, bulk ingredient and retail markets.
Cyanotech’s communications also reference tariff impacts on contract extraction competitiveness and broader macroeconomic conditions that affect demand and product mix, such as shifts between bulk and packaged sales and price sensitivity in certain markets.
Product innovation
The company and its Nutrex-Hawaii subsidiary describe ongoing product innovation within their microalgae-based portfolio. For example, Nutrex-Hawaii announced a sugar‑free, vegan gummy format for BioAstin Hawaiian Astaxanthin, formulated with 12 mg of natural Hawaiian Astaxanthin per daily serving and additional vitamin D3. Cyanotech has also referenced the launch of Hawaiian Spirulina gummies to complement existing astaxanthin gummy products. These developments illustrate how the company adapts its core microalgae ingredients into new consumer-friendly formats.
Position within the medicinal and botanical manufacturing industry
Within the broader medicinal and botanical manufacturing industry, Cyanotech’s distinguishing feature is its focus on microalgae cultivated in Hawaii and its emphasis on natural, sustainably produced dietary ingredients. By combining microalgae cultivation, proprietary processing technology, and branded consumer products, the company participates in both ingredient supply and finished supplement markets. Its long history in microalgae technology and its 96‑acre Kona facility form the backbone of its manufacturing and product development activities.